Atom | National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

Funder: National Institutes of Health

Funding Amounts: No budget limit; project period up to 5 years; budgets must reflect actual project needs.

Summary: Supports multidisciplinary research to discover, develop, and test new drugs, devices, and neurostimulation approaches for mental disorders, with strong encouragement for academia-industry partnerships.

Key Information: Clinical trial optional; companion U19 FOA available for multi-project programs; limited submission—see eligibility details.

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

Sign in to see full grant listing